EVE Health Group Limited (ASX:EVE)
Australia flag Australia · Delayed Price · Currency is AUD
0.0210
0.00 (0.00%)
Feb 11, 2026, 4:10 PM AEST

EVE Health Group Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-1.58-1.9-4.04-5.37-3.63
Depreciation & Amortization
00.010.230.330.32
Loss (Gain) From Sale of Assets
0.070.02-0.050.130
Asset Writedown & Restructuring Costs
--0.090.66-0.33
Loss (Gain) From Sale of Investments
--0.03-0.22--
Loss (Gain) on Equity Investments
--0.250.340.47
Stock-Based Compensation
--0.020.110.19
Provision & Write-off of Bad Debts
--00.01-0
Other Operating Activities
0.030.03-0.050.250.28
Change in Accounts Receivable
0.030.040.070.10.56
Change in Inventory
-0.040.460.61-0.25-0.37
Change in Accounts Payable
-0.110.11-0.05-0.070.26
Operating Cash Flow
-1.62-1.11-1.65-3.77-2.24
Capital Expenditures
---0-0.03-0.26
Sale of Property, Plant & Equipment
2.130.840.02--
Cash Acquisitions
0----
Divestitures
--0.15--
Investment in Securities
-0.030.33--
Investing Cash Flow
2.130.870.5-0.03-0.26
Short-Term Debt Issued
0.430.760.12--
Long-Term Debt Issued
---0.11-
Total Debt Issued
0.430.760.120.11-
Short-Term Debt Repaid
-1.06-0.61-0.05--
Long-Term Debt Repaid
--0-0.04-0.37-0.11
Total Debt Repaid
-1.06-0.61-0.09-0.37-0.11
Net Debt Issued (Repaid)
-0.630.150.02-0.27-0.11
Issuance of Common Stock
1.03-0.222.140.66
Other Financing Activities
-0.12--0.01-0.14-0.02
Financing Cash Flow
0.280.150.241.740.53
Miscellaneous Cash Flow Adjustments
----0-
Net Cash Flow
0.8-0.09-0.91-2.06-1.98
Free Cash Flow
-1.62-1.11-1.65-3.8-2.51
Free Cash Flow Margin
-93.13%-51.88%-70.83%-189.02%-89.52%
Free Cash Flow Per Share
-0.01-0.01-0.01-0.04-0.03
Cash Interest Paid
0.030.070.030.020.02
Levered Free Cash Flow
0.540.75-3.18-2.34-1.83
Unlevered Free Cash Flow
0.540.75-3.18-2.33-1.79
Change in Working Capital
-0.130.610.63-0.220.45
Source: S&P Global Market Intelligence. Standard template. Financial Sources.